These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1673263)

  • 21. CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice.
    Budd RC; Russell JQ; van Houten N; Cooper SM; Yagita H; Wolfe J
    J Immunol; 1992 Feb; 148(4):1055-64. PubMed ID: 1346621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
    Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S; Boumsell L; Dausset J; Degos L; Bernard A
    Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lepromin-induced lymphoproliferative response of experimental leprosy monkeys: regulatory role of monocyte and lymphocyte subsets.
    Ohkawa S; Martin LN; Gormus BJ
    J Immunol; 1987 Jun; 138(11):3943-8. PubMed ID: 2953794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor requirements for activation and proliferation steps of human CD2+CD3-CD4-CD8- early thymocytes.
    Dalloul AH; Mossalayi MD; Dellagi K; Bertho JM; Debré P
    Eur J Immunol; 1989 Nov; 19(11):1985-90. PubMed ID: 2574677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-CD2 antibodies induce T cell unresponsiveness in vivo.
    Gückel B; Berek C; Lutz M; Altevogt P; Schirrmacher V; Kyewski BA
    J Exp Med; 1991 Nov; 174(5):957-67. PubMed ID: 1682413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique epitope on the CD2 molecule defined by the monoclonal antibody 9-1: epitope-specific modulation of the E-rosette receptor and effects on T-cell functions.
    Bernard A; Knowles RW; Naito K; Dupont B; Raynal B; Tran HC; Boumsell L
    Hum Immunol; 1986 Dec; 17(4):388-405. PubMed ID: 2432048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo.
    Bromberg JS; Chavin KD; Altevogt P; Kyewski BA; Guckel B; Naji A; Barker CF
    Transplantation; 1991 Jan; 51(1):219-25. PubMed ID: 1670971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
    Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
    J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
    J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of CD2-/CD3+ T cells in fetal human tissue.
    Kabelitz D; Conradt P
    J Exp Med; 1988 Nov; 168(5):1941-6. PubMed ID: 2903216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel subset of CD2-, CD3/T cell receptor alpha/beta+ human peripheral blood T cells. Phenotypic and functional characterization of interleukin 2-dependent CD2-CD3+ T cell clones.
    Kabelitz D; Conradt P; Schondelmaier S; Wagner H; Haars R
    J Exp Med; 1989 Aug; 170(2):559-69. PubMed ID: 2569027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of HLA-DR and interleukin-6 gene transcription in resting T cells via the CD2 molecule: relevance to chronic immune-mediated inflammation.
    Linardopoulos S; Corrigall V; Panayi GS
    Scand J Immunol; 1992 Sep; 36(3):469-77. PubMed ID: 1355612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sheep erythrocyte rosetting induces multiple alterations in T lymphocyte function: inhibition of T cell receptor activity and stimulation of T11/CD2.
    Breitmeyer JB; Faustman DL
    Cell Immunol; 1989 Oct; 123(1):118-33. PubMed ID: 2570643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta.
    Rudick RA; Carpenter CS; Cookfair DL; Tuohy VK; Ransohoff RM
    Neurology; 1993 Oct; 43(10):2080-7. PubMed ID: 8105424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron exerts a specific inhibitory effect on CD2 expression of human PBL.
    Carvalho GS; de Sousa M
    Immunol Lett; 1988 Oct; 19(2):163-7. PubMed ID: 2906908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
    Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
    J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.